Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- Check6 days agoChange DetectedThe website version is updated from v3.5.3 to v3.5.4, indicating an under-the-hood update to the platform. No study text or data were changed on the page.SummaryDifference0.0%

- Check13 days agoChange DetectedA new citation has been added to Publications for an immunotherapy article by Davis et al., with full bibliographic details. This adds additional reference material for readers.SummaryDifference0.0%

- Check20 days agoChange DetectedThe study page text did not change; the content described in the provided page context remains the same, including the study overview, eligibility criteria, and listed locations.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page’s displayed interface revision was updated from v3.5.2 to v3.5.3, indicating a non-content system/version change rather than a change to the clinical trial information.SummaryDifference0.1%

- Check34 days agoChange DetectedExpanded Access record added and availability noted outside the clinical trial; new locations Calgary, Canada and Roma, Italy are listed with updated address formatting, and the revision version updated to v3.5.2 (replacing the prior v3.5.0 entries).SummaryDifference0.5%

- Check63 days agoChange DetectedThe page now displays Revision: v3.5.0 and no longer displays Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.